Bioventus (BVS) Shares Outstanding (Diluted) (2021 - 2026)
Bioventus (BVS) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.00 Bn | 175.71 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 128.69 Bn | 125.81 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 47.97 Bn | 44.30 Bn | 1.29 Bn | 580.70 Mn |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.00 Bn | 1.98 Bn | 457.00 Mn |
| 7 | Dexcom | 28.21 Bn | 27.09 Bn | 750.30 Mn | 393.60 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | 873.00 Mn |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 968.53 Mn |
| 10 | Bioventus | 824.38 Mn | 788.53 Mn | 90.77 Mn | 70.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 70.01 Mn |
| Dec 31, 2025 | 68.91 Mn |
| Sep 27, 2025 | 68.84 Mn |
| Jun 28, 2025 | 68.54 Mn |
| Mar 29, 2025 | 66.01 Mn |
| Dec 31, 2024 | 64.55 Mn |
| Sep 28, 2024 | 65.26 Mn |
| Jun 29, 2024 | 64.06 Mn |
| Mar 30, 2024 | 63.38 Mn |
| Dec 31, 2023 | 62.65 Mn |
| Sep 30, 2023 | 62.82 Mn |
| Jul 1, 2023 | 62.55 Mn |
| Apr 1, 2023 | 62.12 Mn |
| Dec 31, 2022 | 61.39 Mn |
| Oct 1, 2022 | 61.67 Mn |
| Jul 2, 2022 | 61.48 Mn |
| Apr 2, 2022 | 60.48 Mn |
| Dec 31, 2021 | 45.47 Mn |
| Oct 2, 2021 | 41.84 Mn |
| Jul 3, 2021 | 41.81 Mn |